Investigation of Jchain epitope presentation in a larger MM cohort will be needed to explore mechanisms of aberrant Jchain CYT-A24 epitope presentation and to clarify the proportion of patients that would benefit from clinical development of Jchain TCRs. Here, JCHAIN is linked to Miyoshi myopathy.